Home
Search results “Pharmaceutical biomedical analysis journal”
Avoid the perils of using rounded data
 
05:05
This video contains the 'Audioslides' which accompany the scientific publication entitled 'Avoid the perils of using rounded data' published in the Journal of Pharmaceutical and Biomedical Analysis in Nov 2015 (http://www.sciencedirect.com/science/article/pii/S0731708515300753) Highlights: 1. From a technical point of view it is always better to work with unrounded data. 2. Implications of using rounded data in calculations and visualisation are discussed. 3. Data are recommended to have at least 2 more decimal places than the reported format. 4. The impact of using nominal and effective specification limits is described. 5. Effective specification limits are recommended for specification based statistics.
Views: 2814 Dr. Phil Borman
Audioslides presentation for JPBA Klara Valko updated
 
07:47
This video serves as audio slides for my review paper to be published in Journal of Pharmaceutical and Biomedical Analysis in 2016. The title of the paper is: Lipophilicity and biomimetic properties measured by HPLC to support drug discovery
Views: 73 Klara Valko
Relaunch of The Pharmaceutical Journal and Clinical Pharmacist by RPS
 
02:29
The Pharmaceutical Journal (http://www.pharmaceutical-journal.com), the official journal of the Royal Pharmaceutical Society, which caters for Pharmacists and Pharmaceutical Scientists, is relaunched after 175 years from a 32-page weekly publication into a new 64-page monthly publication. The journal will continue to cover news, analysis, features, opinion, learning and career features. It will provide the fundamental insight and knowledge about drugs, their discovery, approval and application in the context of the pharmacy profession and pharmaceutical sciences. From January 2016 Clinical Pharmacist (http://www.pharmaceutical-journal.com/publications/clinical-pharmacist/) will publish peer-reviewed Review articles on topics from drug discovery to clinical pharmacology and pharmacy that provide insight into future developments and a balanced take on emerging ideas and trends. Perspective articles on timely subjects of recent advancement or areas of controversy, and evidence-based CPD articles and Practice Reports on best practice in pharmacy and pharmaceutical sciences.
A biomarker saving lives | Rasha Hanafi | TEDxGUC
 
09:40
Day after day countless individuals suffer from heart related diseases, specifically, heart attacks; many cases of which, unfortunately, lead to death. With the constant improvements in today’s medical world, there are now numerous ways to deal with the side effects, and potentially resolve them. Dr. Rasha Hanafy will discuss with us in this talk her latest research in detecting early on- set heart attacks with her research team in the German University in Cairo, and controlling their ruthless side effects. Asc. Prof. Dr. Rasha Hanafi is associate professor of pharmaceutical and Biomedical analysis at the faculty of Pharmacy and Biotechnology of the German University in Cairo.She obtained her bachelor and masters degrees from the faculty of Pharmacy of Cairo University and was the first to obtain a PhD degree from the German University in Cairo in pharmaceutical sciences in 2009. She is currently teaching instrumental analysis and analytical chemistry for pharmacy students and is responsible of the central research laboratory of the faculty. She has more than 20 publications in international journals and has represented the faculty in more than 20 national an international conferences. She has more than 15 masters and PhD students from the GUC and other universities. She is also a Scientific Consultant for the Egyptian pharmaceutical industry and a Free Lance Trainer in the field of analytical Method development. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Views: 756 TEDx Talks
The submission process from the publisher's point of view
 
19:53
Jonathan Patience, Senior Editor at Taylor & Francis, outlines the pathway to publication; encompassing the initial decision, peer review, revision and acceptance. Recorded 13 June 2018 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = ABSTRACT: Taylor & Francis Group, an Informa business, publishes more than 2,500 journals and over 5,000 new books each year, offering a range of commercial services, including accelerated publishing, supplements, sponsored focus and reprints. The company recently acquired Dove Medical Press, which specialises in the publication of open access journals across the broad spectrum of science, technology and especially medicine. This talk aims to de-mystify the process of manuscript submission to medical journals. From a publisher’s perspective, it covers considerations prior to submission, pre-submission inquiries, the stages your manuscript undergoes after submission, and how to improve your chances of manuscript acceptance. Prior to submission, it is important to check the journal’s author guidelines and aims and scope. The manuscript should be on scope for the journal, have a clear objective explaining what it adds to the literature, and include all requested sections and funding information. At peer review, the most common criticisms we receive for industry-funded papers are that they have a marketing tone, so it is important to be careful of the language used, letting data speak for itself. Other common criticisms include missing references, flawed statistical analysis, lack of transparency or results being over or under-emphasised, and missing p-values in support of claims of significance. To speed up the decision and avoid rejection post-peer review, make sure to provide clear, point-by-point responses to all reviewers’ comments, or rationale where you feel no change is needed. Adding new data, long delays during revision, unclear responses and unaddressed comments can all delay the editorial decision. Written by Jonathan Patience, Senior Editor at Taylor & Francis = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = We are building a library of free webcasts, like this one, for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new topics and speakers. Full details of this MedComms Networking event are at http://medcommsnetworking.com/event_130618.html Jonathan’s presentation (PDF format) is at http://medcommsnetworking.com/presentations/patience_130618.pdf Jonathan’s Linkedin page is at https://www.linkedin.com/in/jonathan-patience-679b1224/ More about Taylor & Francis can be found at http://taylorandfrancis.com/ Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor Editorial support by Penny Gray, Freelance Medical Writer [For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers, Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]
Views: 227 MedComms
MOL2NET (Castilian) Welcome Message by PhD. Verónica Ortiz de Elguea
 
00:58
Description: MOL2NET International Conference, 15–30 November 2015, online, http://sciforum.net/conference/mol2net-1 Content: Welcome message Audio: Spanish Author: PhD. Verónica Ortiz de Elguea Affiliation: Department of Organic Chemistry II, Uinversity of Basque Country, UPV/EHU, Leioa, Bizkaia. Possition: Post-Doctoral Researcher Video Content & Authorship: This video express the personal opinions of this author about the conference and his own work; no language or content verification have been carried out by a third part. The video have been uploaded by the channel owner after request and obtention of permission from author. The copyright of the video is under Standard YouTube License. Chairman Note: MOL2NET is one international scientific conference. The full title of this conference is the 1st International Conference on Synergies of Experimental Groups of Molecular and Biomedical Sciences with Data, Networks, and Social Sciences Experts. MOL2NET (the conference's running title) will be held from 15–30 November 2015 on the SciForum platform. This running title is inspired by the possibility of multidisciplinary collaborations in science between experimentalists and theoretical scientists; represented disciplines will encompass the molecular and biomedical sciences, social networks analysis, and beyond. More specifically, this conference aims to promote scientific synergies between groups of experimental molecular and bio-medical scientists. Relevant fields include chemistry, pharmacology, cancer research, proteomics, the neurosciences, the nanosciences, and epidemiology. Moreover, the conference welcomes computational and social sciences experts from different areas, such as computational chemistry, bioinformatics, social networks analysis, big data predictive analytics, biostatistics, etc. The conference per se is the result of the synergy between the Department of Organic Chemistry, University of Basque Country (UPV/EHU), and IKERBASQUE, Basque Foundation for Sciences, with the Faculty of Informatics, University of Coruña (UDC). Accepted papers will be published in the proceedings of the conference, and selected papers will be considered for publication in IJMS, which is an open access publication journal of MDPI in the field of Molecular and Biomedical Sciences (link: http://www.mdpi.com/journal/ijms). Some of the main topics of interest are explained in the section details. In addition, promotional videos in different languages and additional materials of related topics are expected to be released in MOL2NET YouTube channel of (link: http://bit.do/mol2net), in MOL2NET Twitter account @mol2net (link: https://twitter.com/mol2net), and in MOL2NET Facebook group with +8000 followers interested on topics of molecular and biomedical science and data analysis (link: https://www.facebook.com/groups/chembioinfo.networks/). Please, download and read the editorial of the conference published in the paper ResearchGate 2015, 1, 1-2, doi: 10.13140/RG.2.1.3123.3122 (link: http://www.bit.do/rgmol2net). We also invite all colleagues to share the conference website through social media. Sincerely yours, Conference Chairman Prof. Humberto González-Díaz Ikerbasque Professor (1) Department of Organic Chemistry II, University of the Basque Country UPV/EHU, 48940, Bizkaia, Leioa, Sarriena w/n, Spain; (2) IKERBASQUE, Basque Foundation for Science, 48011, Bilbao, Bizkaia, Spain [email protected] http://www.ikerbasque.net/humberto.gonzalez
Views: 268 gonzalezdiazh
The Use and Misuse of Statistics in Medical Research
 
01:00:22
The misuse of statistics in medical research is more common than one might think. While some may be due to use of the wrong statistical method, it more often reflects a lack of understanding of the purpose of statistical analysis, assumptions of inferential statistical methods, and the connection between statistical methods and research hypotheses. This presentation will identify some of the more common mistakes encountered and how to correct them. Dr. Kolm is Director of Biostatistics at Christiana Care Health System, Research Professor of Medicine at Thomas Jefferson University and Director of the Biostatistical Core of the Bridging Advanced Developments for Exceptional Rehabilitation (BADER) Consortium funded by the Department of Defense. He has over 30 years of experience in consulting with investigators in the design and analysis of clinical trials, retrospective and observational studies, and large patient registries. He has provided statistical reviews for a number of clinical and statistical journals, and currently is the Statistical Editor for the Journal of the American College of Cardiology – Interventions. Dr. Kolm is a co-investigator and lead biostatistician on several NIH- and industry-funded research projects. He has considerable experience in the application of general and generalized linear and hierarchical models, classification and tree regression, time-to-event analysis, multivariate analysis, cost-effectiveness analyses and multiple imputation methods for missing data.
Views: 669 DE-CTR ACCEL
Erectile Dysfunction (E.D.) a fact of Life?
 
03:49
Erectile Dysfunction (E.D.) a fact of Life? It's a nightmare Look, everybody knows what E.D. is and it's a nightmare. Now, maybe... your one of those guys that has been led to believe that your E.D...is just a fact of life or that it's presence in YOUR life is just an artifact of getting older. And for the most. part, that is just simply not true. Body & Mind A Man's penile erection is mediated by two primary mechanisms: PHYSIOLOGIC or the REFLEX erection, achieved by direct contact with the penis and the PSYCHOGENIC erection, achieved by sexually arousing or emotional stimuli. The first utilizes peripheral nerves and the lower parts of the spinal cord, whereas the second uses the limbic system of the brain. Nerves, gases & structures In both cases, an INTACT NEURAL SYSTEM is required for a successful, complete & deployable erection. Stimulation of the penile shaft by the nervous system leads to the secretion of nitric oxide (NO), which causes the relaxation of smooth muscles of corpora cavernosa (the main erectile tissue of penis) and subsequently penile erection. Trauma Spinal cord injury can be on of the causes sexual dysfunction including ED. Restriction of blood flow can arise from impaired endothelial function due to the usual causes associated with coronary artery disease. Testosterone Additionally, adequate levels of TESTOSTERONE (produced by the testicular tissue) and an intact pituitary gland are required for the development of a healthy erectile system. As can be understood from the mechanisms of a normal erection, ED may develop due to hormonal deficiency, disorders of the neural system, lack of adequate penile blood supply or psychological problems.[1] Diagnosis There are no formal tests to diagnose erectile dysfunction. Blood tests are generally done to exclude underlying disease, such as hypogonadism and prolactinoma. Related to ED is also related to generally poor physical health, poor dietary habits, OBESITY, and most specifically CARDIOVASCULAR disease such as coronary artery disease and peripheral vascular disease. Get Treatment Therefore, a thorough physical examination is helpful, in particular the simple search for a previously undetected groin herniasince it can affect sexual functions in men and is easily curable.[2] [1] Rany Shamloul; Anthony J Bella (2014-03-01). Erectile Dysfunction. Biota Publishing. pp. 6–. ISBN 978-1-61504-653-9. [2] Zieren J, Menenakos C, Paul M, Müller JM (2005). "Sexual function before and after mesh repair of inguinal hernia". Journal of pharmaceutical and biomedical analysis. 12(1): 35–38. doi:10.1111/j.1442-2042.2004.00983.x. PMID 15661052. rxevolutionmedical.com
Views: 1504 Rxevolution Medical
Journal Rankings on Pharmaceutical Science
 
01:01
International Journal of Pharmacy, Photon Email: [email protected] is World's Most Read Journal in the area of Pharmacy: Rank #1 World Report. Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Photon Journal Photon Foundation Advanced https://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Drug Delivery Reviews Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics Advanced Drug Delivery Reviews • Drug Delivery • Drug Development and Industrial Pharmacy • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • Opinion on Biological Therapy • Drug Delivery • Therapeutic Patents • Expert Opinion on Therapeutic Targets • Health Economics • Indian Journal of Pharmaceutical Sciences • International Journal of Geriatric Psychiatry • International Journal of Medical Sciences • International Journal of Pharmaceutics • Journal of Controlled Release • Journal of Pharmacy Practice and Research • Molecular Pharmaceutics • The Pharmaceutical Journal • Pharmacognosy Communications • Pharmacognosy Magazine • Pharmacognosy Research • Pharmacognosy Reviews • Pharmacotherapy • Phytotherapy Research • Scientia Pharmaceutica • Acta Facultatis Pharmaceuticae Universitatis Comenianae • Advanced Drug Delivery Reviews • Advances in Therapy • Alimentary Pharmacology & Therapeutics • The American Journal of Pharmaceutical Education • Annales pharmaceutiques françaises • Annals of Pharmacotherapy • Antibiotics and Chemotherapy • Antimicrobial Agents and Chemotherapy • Antiviral Chemistry & Chemotherapy • Antiviral Research • Asian Journal of Pharmaceutics • Bangladesh Journal of Pharmacology • Behavioural Pharmacology (journal) • Biochemical Pharmacology • BioDrugs • Biological & Pharmaceutical Bulletin • British Journal of Clinical Pharmacology • British Journal of Pharmacology • Canadian Journal of Physiology and Pharmacology • Canadian Pharmacists Journal • Cancer Chemotherapy and Pharmacology • China Pharmacy • Clin-Alert • Clinical and Experimental Pharmacology and Physiology • Clinical Pharmacokinectics • Clinical Pharmacology & Therapeutics • Clinical Pharmacology: Advances and Applications • Clinical Therapeutics • CNS Drugs (journal) • CNS Neuroscience & Therapeutics • The Consultant Pharmacist • Core Evidence • Current Drug Metabolism • Pharmacology • Current Pharmaceutical Design • Current Trends in Biotechnology and Pharmacy Drug and Therapeutics Bulletin • Drug Delivery • Drug Design, Development and Therapy • Drug Development and Industrial Pharmacy • Drug Discovery Today • Drug Metabolism and Disposition • Drug Metabolism Reviews • Drug Research (journal) • Drug Target Insights • Drug Testing and Analysis • Drugs (journal) • Drugs & Aging • Environmental Toxicology and Pharmacology • European Journal of Clinical Pharmacology • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • European Journal of Pharmacology • European Neuropsychopharmacology • Experimental and Clinical Psychopharmacology • Expert Opinion on Drug Delivery • Expert Opinion on Drug Discovery • Expert Opinion on Drug Metabolism & Toxicology • Expert Opinion on Drug Safety • Expert Opinion on Emerging Drugs • Expert Opinion on Investigational Drugs • Expert Opinion on Pharmacotherapy Theses and dissertations Networked Digital Library of Theses and Dissertations, NDLTD Finding theses and dissertations Theses Library University Library International Theses Research Methodology Review of Literature Results and Discussion, International Library for Thesis
Views: 35 Xing Xing
First Digital Pill Has Been Approved By The FDA
 
05:27
FDA approves first digital pill. The first pill which can be digitally tracked as it makes its way through the body has been approved for use by the US safety drugs watchdog, the Food and Drug Administration FDA. http://www.futuretimeline.net/blog/2017/11/15.htm#.WhC3F1VKvIU http://www.pharmaceutical-journal.com/sign-in?rtn=news-and-analysis/news/fda-approves-first-digital-pill/20203940.article If You Would like to donate for my work click the link below. Thank You. https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=NKSD2EZ2JSNQJ -~-~~-~~~-~~-~- Please watch: "Hurricane Season 2018 Outlook with J7409" https://www.youtube.com/watch?v=zMcrwQhBZ0U -~-~~-~~~-~~-~-
Views: 743 J7409
International Journal of Pharmacy and Pharmaceutical Science
 
01:01
International Journal of Pharmacy, Photon Email: [email protected] is World's Most Read Journal in the area of Pharmacy: World Report, 2015 Rank #1 Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Photon Journal Photon Foundationhttps://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Advanced Drug Delivery Reviews Photon Journal, Photon Foundation, Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical https://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics
Views: 175 Xing Xing
Science Literacy | 2.3 Scientific Consensus - Can It Be Corrupted?
 
07:29
Can science be corrupted? Many people claim fraud is rampant in science, that scientific results are not to be trusted, that big corporate and political interests go can as far as distorting the scientific consensus on a topic. Do any of these claims have merit? Facebook page: https://www.facebook.com/ScienceLiteracyChannel Twitter page: https://twitter.com/SciLiteracyChan SOURCES: 0:47 : Martinson et al. “Scientists Behaving Badly”. Nature. 9 Jun 2005. http://pages.stolaf.edu/ross/files/2014/05/ScientistsBehavingBadly.pdf 1:15 : Kalichman, MW & Friedman, PJ. “A pilot study of biomedical trainees' perceptions concerning research ethics.” Nov. 1992. Academic medicine : journal of the Association of American Medical Colleges. http://www.ncbi.nlm.nih.gov/pubmed/1418260 Eastwood et al. “Ethical issues in biomedical research: perceptions and practices of postdoctoral research fellows responding to a survey.” Jan. 1996. Science and engineering ethics. http://www.ncbi.nlm.nih.gov/pubmed/11657788 List et al. “Academic economists behaving badly?: A survey on three areas of unethical behavior.” Economic Inquiry. Jan. 2001. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=253099 Geggie, D. “A survey of newly appointed consultants' attitudes towards research fraud”. 2001. Journal of Medical Ethics. http://jme.bmj.com/content/27/5/344 Gardner et al. 2005. “Authors' reports about research integrity problems in clinical trials.” 16 Nov. 2004. http://www.contemporaryclinicaltrials.com/article/S1551-7144%2805%2900008-X/abstract Henry et al. “Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.” Medical Journal of Australia. 6 Jun. 2005. http://www.ncbi.nlm.nih.gov/pubmed/15938681 1:22 : Fanelli, D. “How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data”. PLOS ONE. 29 May 2009. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005738 1:52 : Titus et al. “Repairing research integrity”. Nature. 19 Jun. 2008. http://www.nature.com/nature/journal/v453/n7198/full/453980a.html 2:08 : MacGill, M. “Fraudulent clinical trials known to FDA ‘hidden from journals and public’”. Medical News Today. 10 Feb. 2015. 2:34 : Stern et al. “Research: Financial costs and personal consequences of research misconduct resulting in retracted publications”. eLife. 14 Aug. 2014. http://elifesciences.org/content/3/e02956 3:39 : Franco et al. “Social science. Publication bias in the social sciences: unlocking the file drawer.” Science. 19 Sep. 2014. https://www.ncbi.nlm.nih.gov/pubmed/25170047
Views: 613 Science Literacy
Message from Therapeutic Innovation & Regulatory Science Editor-in-Chief Dr. Stephen Spielberg
 
03:16
DIA's new Therapeutic Innovation & Regulatory Science rebrands the Drug Information Journal, which DIA proudly published for 46 years. The scope of Therapeutic Innovation & Regulatory Science reaches beyond pharmaceutical research and development to include innovations in drugs, devices, and diagnostics, as well as global regulatory issues.
Views: 597 DIA
Viral Kansara|Novartis Institutes for Biomedical Research| Ophthamology 2014 | OMICS International
 
28:00
Title:Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents 4th International Conference on Clinical & Experimental Ophthalmology July 14-16, 2014 DoubleTree by Hilton Baltimore, USA OMICS International: http://omicsonline.org Vaccine Conferences: http://conferenceseries.com/immunology-conferences.php Global Medical Conferences: http://conferenceseries.com Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com Global Cancer Conferences: http://cancersummit.org Global Diabetes Conferences: http://diabetesexpo.com Global Dental Conferences: http://dentalcongress.com Global Nursing Conferences: http://nursingconference.com Abstract Melanin is a heterogeneous biopolymer which is present in the front and back of the eye. Due to its acidic and hydrophobic nature, many therapeutic agents bind to melanin-rich ocular tissues such as the iris-ciliary body, choroid and retinal pigment epithelium of the eye. We hypothesized that drugs with high affinity to melanin are linked to higher ocular exposure, with melanin postulated to be a potential depot for such compounds. To test this hypothesis, in vivo ocular and plasma pharmacokinetic (PK) studies of three compounds with high, medium and low melanin affinity were performed in pigmented and non-pigmented rats. Male Sprague-Dawley (non-pigmented) and Brown-Norway (pigmented) rats were used to determine ocular and plasma PK of selected compounds. The PK parameters were determined using Watson LIMS (Non-compartmental analysis). Using a high-throughput chromatography based in vitro assay, we screened 306 compounds of diverse chemical structures for their in vitro melanin affinity (67 – low-; 168 – medium-; 71 – high- affinity). In our in vivo studies, a significant increase in ocular exposures of high affinity (AUCPEC: 73µM*h vs. 2µM*h; AUCretina: 8 µM*h vs. 3µM*h) and medium affinity (AUCPEC: 9µM*h vs. 0.6µM*h; AUCretina: 6µM*h vs. 2.6µM*h) compounds were observed in pigmented rats compared with non-pigmented rats. The increased ocular exposure (in vivo) correlated with increased retention time on the chromatography (in vitro) method. This vitro assay was shown to be predictive of in vivo melanin dependent ocular compound deposition. This approach provided excellent in-vitro-in-vivo correlations (IVIVC). In conclusion, this research suggests that ocular melanin affinity modulates ocular PK and drug retention in the eye, and may influence the pharmacological action of ocular targeted therapeutic agents. Biography: Viral Kansara is the Investigator at the Novartis Institutes for Biomedical Research. He leads Ocular Pharmacokinetics and Drug Delivery laboratory within Pharmacology group. His team focuses on discovery and development of novel targets and delivery systems to treat AMD, diabetic retinopathy and glaucoma. Viral earned his Ph.D. in the field of Pharmaceutical Sciences from AshimMitra’s Laboratory at the University of Missouri-Kansas City. He has authored 2 book chapters and numerous research articles in reputed journals and has been serving as a reviewer for PharmRes, IOVS, AAPS PharmSciTech, and JOPT.
Current Issues in Intestinal Microbiology
 
01:01
Photon Foundation Email: [email protected] is World's Most Read Journal in the area of Microbiology: Rank #1 World Report. Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Photon Journal Photon Foundation Advanced https://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Drug Delivery Reviews Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics Advanced Drug Delivery Reviews • Drug Delivery • Drug Development and Industrial Pharmacy • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • Opinion on Biological Therapy • Drug Delivery • Therapeutic Patents • Expert Opinion on Therapeutic Targets • Health Economics • Indian Journal of Pharmaceutical Sciences • International Journal of Geriatric Psychiatry • International Journal of Medical Sciences • International Journal of Pharmaceutics • Journal of Controlled Release • Journal of Pharmacy Practice and Research • Molecular Pharmaceutics • The Pharmaceutical Journal • Pharmacognosy Communications • Pharmacognosy Magazine • Pharmacognosy Research • Pharmacognosy Reviews • Pharmacotherapy • Phytotherapy Research • Scientia Pharmaceutica • Acta Facultatis Pharmaceuticae Universitatis Comenianae • Advanced Drug Delivery Reviews • Advances in Therapy • Alimentary Pharmacology & Therapeutics • The American Journal of Pharmaceutical Education • Annales pharmaceutiques françaises • Annals of Pharmacotherapy • Antibiotics and Chemotherapy • Antimicrobial Agents and Chemotherapy • Antiviral Chemistry & Chemotherapy • Antiviral Research • Asian Journal of Pharmaceutics • Bangladesh Journal of Pharmacology • Behavioural Pharmacology (journal) • Biochemical Pharmacology • BioDrugs • Biological & Pharmaceutical Bulletin • British Journal of Clinical Pharmacology • British Journal of Pharmacology • Canadian Journal of Physiology and Pharmacology • Canadian Pharmacists Journal • Cancer Chemotherapy and Pharmacology • China Pharmacy • Clin-Alert • Clinical and Experimental Pharmacology and Physiology • Clinical Pharmacokinectics • Clinical Pharmacology & Therapeutics • Clinical Pharmacology: Advances and Applications • Clinical Therapeutics • CNS Drugs (journal) • CNS Neuroscience & Therapeutics • The Consultant Pharmacist • Core Evidence • Current Drug Metabolism • Pharmacology • Current Pharmaceutical Design • Current Trends in Biotechnology and Pharmacy Drug and Therapeutics Bulletin • Drug Delivery • Drug Design, Development and Therapy • Drug Development and Industrial Pharmacy Photon Journal of Microbiology https://sites.google.com/site/photonfoundationorganization/home/photon-journal-of-microbiology Research (journal) • Drug Target Insights • Drug Testing and Analysis • Drugs (journal) • Drugs & Aging • Environmental Toxicology and Pharmacology • European Journal of Clinical Pharmacology • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • European Journal of Pharmacology • European Neuropsychopharmacology • Experimental and Clinical Psychopharmacology Drug Delivery Drug Discovery • Expert Opinion on Drug Metabolism & Toxicology • Expert Opinion on Drug Safety • Expert Opinion on Emerging Drugs • Expert Opinion on Investigational Drugs • Expert Opinion on Pharmacotherapy Theses and dissertations Networked Digital Library of Theses and Dissertations, NDLTD Finding theses and dissertations Theses Library University Library International Theses Research Methodology Review of Literature Results and Discussion, International Library for Thesis
Views: 5 Xing Xing
Microbiology and Toxicology
 
01:01
Photon Journal of Microbiology, Photon Foundation Email: [email protected] is World's Most Read Journal in the area of Pharmacy: Rank #1 World Report. Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Photon Journal Photon Foundation Advanced https://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Drug Delivery Reviews Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics Advanced Drug Delivery Reviews • Drug Delivery • Drug Development and Industrial Pharmacy • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • Opinion on Biological Therapy • Drug Delivery • Therapeutic Patents • Expert Opinion on Therapeutic Targets • Health Economics • Indian Journal of Pharmaceutical Sciences • International Journal of Geriatric Psychiatry • International Journal of Medical Sciences • International Journal of Pharmaceutics • Journal of Controlled Release • Journal of Pharmacy Practice and Research • Molecular Pharmaceutics • The Pharmaceutical Journal • Pharmacognosy Communications • Pharmacognosy Magazine • Pharmacognosy Research • Pharmacognosy Reviews • Pharmacotherapy • Phytotherapy Research • Scientia Pharmaceutica • Acta Facultatis Pharmaceuticae Universitatis Comenianae • Advanced Drug Delivery Reviews • Advances in Therapy • Alimentary Pharmacology & Therapeutics • The American Journal of Pharmaceutical Education • Annales pharmaceutiques françaises • Annals of Pharmacotherapy • Antibiotics and Chemotherapy • Antimicrobial Agents and Chemotherapy • Antiviral Chemistry & Chemotherapy • Antiviral Research • Asian Journal of Pharmaceutics • Bangladesh Journal of Pharmacology • Behavioural Pharmacology (journal) • Biochemical Pharmacology • BioDrugs • Biological & Pharmaceutical Bulletin • British Journal of Clinical Pharmacology • British Journal of Pharmacology • Canadian Journal of Physiology and Pharmacology • Canadian Pharmacists Journal • Cancer Chemotherapy and Pharmacology • China Pharmacy • Clin-Alert • Clinical and Experimental Pharmacology and Physiology • Clinical Pharmacokinectics • Clinical Pharmacology & Therapeutics • Clinical Pharmacology: Advances and Applications • Clinical Therapeutics • CNS Drugs (journal) • CNS Neuroscience & Therapeutics • The Consultant Pharmacist • Core Evidence • Current Drug Metabolism • Pharmacology • Current Pharmaceutical Design • Current Trends in Biotechnology and Pharmacy Drug and Therapeutics Bulletin • Drug Delivery • Drug Design, Development and Therapy • Drug Development and Industrial Pharmacy Photon Journal of Microbiology https://sites.google.com/site/photonfoundationorganization/home/photon-journal-of-microbiology Research (journal) • Drug Target Insights • Drug Testing and Analysis • Drugs (journal) • Drugs & Aging • Environmental Toxicology and Pharmacology • European Journal of Clinical Pharmacology • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • European Journal of Pharmacology • European Neuropsychopharmacology • Experimental and Clinical Psychopharmacology Drug Delivery Drug Discovery • Expert Opinion on Drug Metabolism & Toxicology • Expert Opinion on Drug Safety • Expert Opinion on Emerging Drugs • Expert Opinion on Investigational Drugs • Expert Opinion on Pharmacotherapy Theses and dissertations Networked Digital Library of Theses and Dissertations, NDLTD Finding theses and dissertations Theses Library University Library International Theses Research Methodology Review of Literature Results and Discussion, International Library for Thesis
Views: 20 Xing Xing
The past & future of respiratory health | University of Southampton
 
01:50:38
In the third event from our new series of public lectures, we focus on respiratory health. Featuring keynote lectures from: Professor Jeffrey M Drazen M.D. Editor-in-Chief New England Journal of Medicine. Jeffrey is the editor-in-chief of The New England Journal of Medicine since 2000. He currently holds the positions of senior physician at the Brigham and Women’s Hospital, Distinguished Parker B. Francis Professor of Medicine at Harvard Medical School, professor of physiology at the Harvard School of Public Health, and adjunct professor of medicine at the Boston University School of Medicine. He is an active researcher in respiratory medicine who defined the role of novel endogenous chemical agents in asthma, which led to four new licensed pharmaceuticals. Professor Ratko Djukanovic MD, DM, FRCP Professor of Medicine; Honorary Consultant Physician, University of Southampton. Ratko has held several senior positions, including Directorship of the Division of Infection, Inflammation and Immunity and oversaw the merger of this with the Division of Clinical Neurosciences, forming the new Academic Unit of Clinical and Experimental Sciences. He is also the Director of the National Institute for Health Research Respiratory Biomedical Research Unit (NIHR RBRU), one of three founded in 2008, receiving £6.55 million to support a programme of translational research in major respiratory diseases across the life-course. Professor Stephen T Holgate CBE, FMedSci MRC Clinical Professor of Immunopharmacology, University of Southampton. Stephen is Medical Research Council Clinical Professor of Immunopharmacology and Honorary Consultant Physician at the University of Southampton. His current research focuses on stratifi ed medicine, the role of the epithelium in orchestrating asthma and the evolution of asthma across the lifecourse. He is a Past President of the British Society of Allergy and Clinical Immunology and British Thoracic Society. He is Chair of the European Respiratory Society Scientific Committee, Treasurer of the World Allergy Organization and Member of the Medical Science Committee of Science Europe. He also co-founded Synairgen a publically quoted respiratory drug development company with a focus on lung antiviral defence in asthma, COPD and severe viral infections.
Scanning Probe Microscopy Laboratory
 
00:57
The Bernal Institute houses a wide range of state of the art research equipment and facilities that allow researchers from a broad range of expertise: mechanical, chemical and biomedical engineers; physicists; materials scientists, biologists, mathematicians and chemists, to focus on individual research projects as well as large interdisciplinary research programs. ___________________________________________________________ Ntegra Spectra, an integrated AFM-TERS-SNOM-Raman instrument. It is capable of performing multimodal surface characterisation using probe-based techniques including up to 30 modes of scanning probe microscopy (SPM), scanning near-field optical microscopy (SNOM) as well as tip enhanced Raman spectroscopy (TERS). It can also be used for confocal Raman, fluorescence microscopy as well as confocal laser scanning microscopy. Atomic force microscopy (AFM) which comes under Scanning probe microscopy (SPM) techniques is a very-high resolution imaging technique which is based on the interaction between a sharp probe and a surface. It is capable of measuring nano-scale surface features and investigating nano-scale surface properties using the sharpened probe. Agilent 5500 AFM at Bernal Institute is capable of performing all standard modes of AFM as well as  scanning tunnelling microscopy (STM), nanoTA (thermomechanical analysis sub-100 micron resolution), heated tip AFM (HT-AFM) and scanning thermal microscopy (SThM). __________________________________________________________ Below is a list of some of the equipment and facilities available at the Bernal Institute, for further information please email [email protected] Transmission and Scanning Electron Microscopes Spectral analysis and Surface Characterisation Laboratory Surface Science Laboratory Scanning Probe Microscopy (SPM) Laboratory X-ray Diffraction Suite Solid-state NMR Spectrometer (SSNMR) Automated Tape Placement (ATP) Crystallisation Research Pilot Thermal Analysis Suite Thermoclave Pharmaceutical Processing Suite Confocal Microscope Porous Materials Characterisation Lab Crystallisation Research Pilot Bubbly Flow Channels Microfluidics Laboratories Sustainable Chemical Transformations Suite Spectro-electroanalysis Facilities Bioprocessing (BioPoint) Follow us on Twitter : https://twitter.com/BernalNews And LinkedIN : https://www.linkedin.com/showcase/bernal-institute/
Online Course for USP Chapter 1029 (Good Documentation Guidelines) - Teaser
 
04:45
Product Description Speaker Bio: Dr. Afsaneh Motamed Khorasani is a Medical and scientific Affairs expert and a Senior Scientist with a strong background in biomedical science and clinical trial/research. She has a tenured and diverse range of experience in medical affairs, basic and industrial clinical research and development, clinical trials, Medical and regulatory writing and intellectual property. She is currently the Vice President of Medical Affairs at Easy Global Training, which is a US-based firm providing global regulatory, quality and medical affairs training backed by consulting. Before joining this company, Dr. Motamed Khorasani has served as an independent consultant, director of medical affairs, senior medical sciences liaison, senior scientist and senior medical analyst at Merck (MDS), Johnson & Johnson, United States Pharmacopoeia Convention (USP), Amgen, Baxter International, Covidien (eV3), Radient Pharmaceuticals, AMDL Diagnostics, Microbix Biosystems, Neometrix Consulting, Mount Sinai Hospital, Princess Margaret Hospital, and Vancouver General Hospital. She has more than 20 years of experience and many National and international certificates in GLP, GMP, ICH-GCP and global regulatory compliance for clinical trials and is a member in a number of professional associations, including: American Association of Cancer Research (AACR), American Medical Writers Association (AMWA), Regulatory Affairs Professional Society (RAPS), American Society of Quality (ASQ), Project Management Institute (PMI), and Intellectual Property Institute of Canada (IPIC). Dr. Motamed Khorasani’s research has focused on high throughput approaches in the context of cancer informatics with a particular interest in the use of comparative analysis for the mining of integrated oncology data sets that include protein-protein interaction and gene expression profiling. She has published and presented more than 50 papers, abstracts and articles in highly regarded scientific journals and high profile conferences and scientific meetings. On-Demand Webinar Overview Good documentation Practices (GDP) is an essential factor that needs to be closely followed by the personnel in any regulated environment as a process for a successful project completion including observations of unanticipated responses that are required to be accurately recorded and verified. This 1-hour On-Demand Webinar covers the newly published USP General Chapter 1029 “Good Documentation Guidelines”. View the 5 minute Teaser Here: https://youtu.be/Akvos8TDlhw View the list of all of our products Here: http://www.easyglobaltraining.com Learning Highlights After this 60 minute webinar, you will become familiar with the USP General Chapter 1029 in Good Documentation Guidelines which adds some high level information to all other Good documentation rules and regulations out there. This will wrap up the general concept and will provide the information as to what needs to be documented in certain records. The outline of the discussion includes: History of the chapter as to how and why it was created Purpose of development of this chapter Chapter outline: Principles of Good Documentation Data collection & recording Different types of GMP Documents: Laboratory records Equipment-related documentation Deviations and investigations Batch records Certificate of Analysis (C of A) Standard Operating Procedure (SOP) Protocols & reports Analytical procedures Training documentation Retention of documents Who Can Benefit From This Course Anybody who works in a regulated environment Manufacturing & Production Personnel / Managers Research and Development Personnel (R&D) / Managers Quality Assurance & Quality Control Personnel / Managers Laboratory Personnel / Managers Validation Specialists Clinical trial personnel Project Managers Details ID: 778 SKU: OW-BP-0001 Type: On-Demand Webinar Format: Video MP4 Play Back Date of Last Update: Jan 15, 2017 Duration: 60 minutes Course Level: Intermediate Price: $199.00 Notes Upon Check out, check your basket to make sure you have the right products for your need. Fill out the billing information and enter Coupon Code if you have one. Press “Proceed to PayPal” to pay for your selected products in the basket. You will be directed to PayPal for payment, where you can pay with a credit (Visa, Master Card, American Express, and Discover) or debit card (You do not need a PayPal account). After purchase, you will be redirected back to the website. The link to view the On-Demand Webinar along with the link to download the PDF version of the slides will be sent to you in the e-mail you will receive upon your registration and payment.
Research in Microbiology
 
01:01
Photon Journal of Microbiology, Photon Foundation Email: [email protected] is World's Most Read Journal in the area of Pharmacy: Rank #1 World Report. Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Photon Journal Photon Foundation Advanced https://sites.google.com/site/photonfoundationorganization/international-journal-of-pharmacy Drug Delivery Reviews Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics Advanced Drug Delivery Reviews • Drug Delivery • Drug Development and Industrial Pharmacy • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • Opinion on Biological Therapy • Drug Delivery • Therapeutic Patents • Expert Opinion on Therapeutic Targets • Health Economics • Indian Journal of Pharmaceutical Sciences • International Journal of Geriatric Psychiatry • International Journal of Medical Sciences • International Journal of Pharmaceutics • Journal of Controlled Release • Journal of Pharmacy Practice and Research • Molecular Pharmaceutics • The Pharmaceutical Journal • Pharmacognosy Communications • Pharmacognosy Magazine • Pharmacognosy Research • Pharmacognosy Reviews • Pharmacotherapy • Phytotherapy Research • Scientia Pharmaceutica • Acta Facultatis Pharmaceuticae Universitatis Comenianae • Advanced Drug Delivery Reviews • Advances in Therapy • Alimentary Pharmacology & Therapeutics • The American Journal of Pharmaceutical Education • Annales pharmaceutiques françaises • Annals of Pharmacotherapy • Antibiotics and Chemotherapy • Antimicrobial Agents and Chemotherapy • Antiviral Chemistry & Chemotherapy • Antiviral Research • Asian Journal of Pharmaceutics • Bangladesh Journal of Pharmacology • Behavioural Pharmacology (journal) • Biochemical Pharmacology • BioDrugs • Biological & Pharmaceutical Bulletin • British Journal of Clinical Pharmacology • British Journal of Pharmacology • Canadian Journal of Physiology and Pharmacology • Canadian Pharmacists Journal • Cancer Chemotherapy and Pharmacology • China Pharmacy • Clin-Alert • Clinical and Experimental Pharmacology and Physiology • Clinical Pharmacokinectics • Clinical Pharmacology & Therapeutics • Clinical Pharmacology: Advances and Applications • Clinical Therapeutics • CNS Drugs (journal) • CNS Neuroscience & Therapeutics • The Consultant Pharmacist • Core Evidence • Current Drug Metabolism • Pharmacology • Current Pharmaceutical Design • Current Trends in Biotechnology and Pharmacy Drug and Therapeutics Bulletin • Drug Delivery • Drug Design, Development and Therapy • Drug Development and Industrial Pharmacy • Drug Discovery Today • Drug Metabolism and Disposition • Drug Metabolism Reviews https://sites.google.com/site/photonfoundationorganization/home/photon-journal-of-microbiology Environmental Toxicology and Pharmacology • European Journal of Clinical Pharmacology • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • European Journal of Pharmacology • European Neuropsychopharmacology • Experimental and Clinical Psychopharmacology • Expert Opinion on Drug Delivery • Expert Opinion on Drug Discovery • Expert Opinion on Drug Metabolism & Toxicology • Expert Opinion on Drug Safety • Expert Opinion on Emerging Drugs • Expert Opinion on Investigational Drugs • Expert Opinion on Pharmacotherapy Theses and dissertations Networked Digital Library of Theses and Dissertations, NDLTD Finding theses and dissertations Theses Library University Library International Theses Research Methodology Review of Literature Results and Discussion, International Library for Thesis
Views: 58 Xing Xing
MOL2NET (Euskera) Welcome Message by PhD. Eider Aranzamendi
 
01:00
Description: MOL2NET International Conference, 15–30 November 2015, online, http://sciforum.net/conference/mol2net-1 Content: Welcome message Author: PhD. Eider Aranzamendi Uruburu Email: [email protected] Audio: Euskera (Basque Language) Affiliation: Department of Organic Chemistry II, Uinversity of Basque Country, UPV/EHU, Leioa, Bizkaia. Possition: Post-Doctoral Researcher Video Content & Authorship: This video express the personal opinions of this author about the conference and his own work; no language or content verification have been carried out by a third part. The video have been uploaded by the channel owner after request and obtention of permission from author. The copyright of the video is under Standard YouTube License. Chairman Message: MOL2NET is one international scientific conference. The full title of this conference is the 1st International Conference on Synergies of Experimental Groups of Molecular and Biomedical Sciences with Data, Networks, and Social Sciences Experts. MOL2NET (the conference's running title) will be held from 15–30 November 2015 on the SciForum platform. This running title is inspired by the possibility of multidisciplinary collaborations in science between experimentalists and theoretical scientists; represented disciplines will encompass the molecular and biomedical sciences, social networks analysis, and beyond. More specifically, this conference aims to promote scientific synergies between groups of experimental molecular and bio-medical scientists. Relevant fields include chemistry, pharmacology, cancer research, proteomics, the neurosciences, the nanosciences, and epidemiology. Moreover, the conference welcomes computational and social sciences experts from different areas, such as computational chemistry, bioinformatics, social networks analysis, big data predictive analytics, biostatistics, etc. The conference per se is the result of the synergy between the Department of Organic Chemistry, University of Basque Country (UPV/EHU), and IKERBASQUE, Basque Foundation for Sciences, with the Faculty of Informatics, University of Coruña (UDC). Accepted papers will be published in the proceedings of the conference, and selected papers will be considered for publication in IJMS, which is an open access publication journal of MDPI in the field of Molecular and Biomedical Sciences (link: http://www.mdpi.com/journal/ijms). Some of the main topics of interest are explained in the section details. In addition, promotional videos in different languages and additional materials of related topics are expected to be released in MOL2NET YouTube channel of (link: http://bit.do/mol2net), in MOL2NET Twitter account @mol2net (link: https://twitter.com/mol2net), and in MOL2NET Facebook group with +8000 followers interested on topics of molecular and biomedical science and data analysis (link: https://www.facebook.com/groups/chembioinfo.networks/). Please, download and read the editorial of the conference published in the paper ResearchGate 2015, 1, 1-2, doi: 10.13140/RG.2.1.3123.3122 (link: http://www.bit.do/rgmol2net). We also invite all colleagues to share the conference website through social media. Sincerely yours, Conference Chairman Prof. Humberto González-Díaz Ikerbasque Professor (1) Department of Organic Chemistry II, University of the Basque Country UPV/EHU, 48940, Bizkaia, Leioa, Sarriena w/n, Spain; (2) IKERBASQUE, Basque Foundation for Science, 48011, Bilbao, Bizkaia, Spain [email protected] http://www.ikerbasque.net/humberto.gonzalez
Views: 454 gonzalezdiazh
Tough Targets. Simple Genotyping. Complete Solutions for Mitochondrial Disease
 
45:52
Presented at Clinical Diagnostics & Research 2017: https://www.labroots.com/virtual-event/clinical-diagnostics-research Dana Sullivan Product Manager, Canon Biomedical Dana Pfister Sullivan received her Masters in Biotechnology, from Johns Hopkins University, with a focus in molecular targets and drug design. She has worked in various areas of the biotechnology industry, including pharmaceutical, life science, and molecular diagnostic in both research and development as well as commercial. Dana has five years of practical experience at the laboratory bench, and her work has been published in peer-reviewed journals and presented at international conferences. Dana joined Canon BioMedical as Product Manager shortly after the first launch of the Novallele Genotyping Assays. She is passionate about partnering with life scientists and researchers to develop the next wave of biomedical solutions. Webinar: Keynote Presentation: Tough Targets. Simple Genotyping. Complete Solutions for Mitochondrial Disease, CRISPR, Pharmacogenetics, and Neuroscience Research Do you have targets that are difficult to genotype? Are you starting new projects and looking for a fast, convenient genotyping solution? Whether detecting mitochondrial disease targets, screening CRISPR clones, exploring pharmacogenetic interactions, or distinguishing genotypes for neurological disorders — PCR followed by high-resolution melting (HRM) is a fast, reliable, and inexpensive genotyping method to get the answers you need for your experiments. Canon BioMedical developed a library of common and unique targets for identifying single-nucleotide polymorphisms (SNPs), indels, and large deletions. Unlike most other genotyping techniques, HRM analysis can genotype a single sample in an hour. The Novallele™ genotyping assays are run on any HRM-capable thermocycler, and corresponding control DNA is available for wild-type DNA as well as homozygous and heterozygous variants. The Novallele HRM Analyzer — free, web-based software — harmonizes your HRM analyses into a single analysis tool. Attend our session to learn how Canon BioMedical can help you with your research. The products mentioned are for Research Use Only. Not for use in diagnostic procedures. Sponsored By: Canon Biomedical Earn PACE Credits: 1. Make sure you’re a registered member of LabRoots: https://www.labroots.com/virtual-event/clinical-diagnostics-research 2. Watch the webinar on YouTube above or on the LabRoots Website: https://www.labroots.com/virtual-event/clinical-diagnostics-research 3. Click Here to get your PACE (November 9th, 2019)– http://www.labroots.com/credit/pace-credits/2534/third-party LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc
Views: 51 LabRoots
Scientific Studies: Last Week Tonight with John Oliver (HBO)
 
19:28
John Oliver discusses how and why media outlets so often report untrue or incomplete information as science. Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight
Views: 14147555 LastWeekTonight
Privacy vs Convenience in Personal Genetic Tech
 
02:13
Complete video at: http://fora.tv/2009/05/19/A_Closer_Look_at_Personal_Genomic_Testing A panel of DNA policy and research experts connect the openness affiliated with the web 2.0 phenomenon to the growing acceptance for personal genetic testing. "We have a different sensitivity to privacy because there are stigmas in previous generations that we just don't have anymore," says 23andMe co-founder Linda Avey. ----- Personal genomic testing (the analysis of the DNA of individuals) is now available for less than $400. The consequences of personal genetic testing are often debated, with advocates arguing that genetic data can lead to improved health care and critics warning that consumers may be unduly worried upon learning results. California regulations impose conditions on firms providing personal genomic testing. This symposium examines genomic testing technology, its ramifications, government regulation of the industry, and whether individuals should have their genome analyzed. - Commonwealth Club of California Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. Daniel Ballon is Senior Policy Fellow in Technology Studies at the Pacific Research Institute. Dr. Ballon's research focuses on policies which promote innovation in the technology sector. He previously spent ten years conducting applied research in biotechnology, and his work has been published in leading biomedical journals. David C. Magnus, Ph.D. is Associate Professor of Pediatrics and Medicine, Stanford University. Magnus is also Director of the Stanford Center for Biomedical Ethics.
Views: 2009 FORA.tv
Top 10 Health Benefits of Berry | Health Care Tips | Berries Benefits
 
02:58
Top 10 Health Benefits of Berry | Health Care Tips | Berries Benefits Don't Forget To Subscribe Our Channel https://www.youtube.com/channel/UCUm67QcbNn5BWKRpydQWIIw In this video we are going to talk about Top 10 Health Benefits of Berry. Berries are one of the juicy fruits ever. Not only the taste, but berries have many health benefits. The synthetic mixes in Berries battle the fundamental irritation that causes hypertension, and help to make our body more advantageous by and large. The Journal of Pharmaceutical and Biomedical Analysis proposes that, flavonoids and different mixes found in Berries may lessen the danger of colon disease. ----------------------------------------------------------------- Key Points of the Video: ---------------------------------------- Berries are Good for High Blood Pressure Berries Fight Cancer Berries Keep You Mentally Sharp Berries are Good for Weight Control Berries Prevent Parkinson's disease Berries Prevent Alzheimer's Disease Berries are Rich in Antioxidants Berries are Good for Skin Berries Improve digestive system Berries are High in Fiber --------------------------------------------------------- More Videos On Our Channel: ----------------------------------------------- Top 10 Health Benefits of Olive | Health Care Tips | Olive Oil Benefits https://youtu.be/iIO2w_BDkqA Top 10 Health Benefits of Lemon | Health Care Tips | Lemon Benefits https://youtu.be/vwuboQGAQIs Top 10 Health Benefits of Grapes | Health Care Tips | Grapes Benefits https://youtu.be/-WYkUFk8pk0 Top 10 Health Benefits of Coconut | Health Care Tips | Coconut Benefits https://youtu.be/r8cXrRJpYqo Top 10 Health Benefits of Avocado | Health Care Tips | Avocado Benefits https://youtu.be/sKjFWT1g4fM ----------------------------------------------- Social Link: Follow Us On Twitter https://twitter.com/Ex_HealthCare Join Us On Google https://plus.google.com/115731971672700482358 ------------------------------------------------------------------------------------ Daily Beetle by Kevin MacLeod is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1500025 Artist: http://incompetech.com/ --------------------------------------------------- Watch This Video Again: https://youtu.be/QihDOBj_Phk
Cancer Research Discovery Announced by Two Biotechnology Companies
 
01:26
Two innovative medical technology companies, InSilico Medicine, Inc. and Champions Oncolology, Inc., have discovered what may prove to be a “green light” tool in colon cancer treatment; a tool that helps doctors choose the most promising path to treat a patient when so many other treatment options are available. The discovery may lead to more effective treatment of colon cancer. Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and the second leading cause of cancer deaths in the United States. More than 50,000 people die of CRC each year and almost half of all newly diagnosed patients are in an advanced stage of cancer (metastatic CRC) when they are first diagnosed. Because of the relatively low response rates of cancer patients to different drug regimens, researchers with InSilico Medicine and Champions Oncology set out to find biological signals or biomarkers in cancerous tumors that might predict in advance whether a patient is likely to respond to a drug treatment. Researchers focused on cetuximab, which is an antibody used in the targeted treatment of CRC patients who do not have a mutation of the K-ras gene. Yet, despite its approval by the FDA for use in these patients, cetuximab is successful in 40 to 60% of these cases. According to a joint paper just released by Champions Oncology and InSilico Medicine, the two companies have identified a biological indicator that may predict in advance the likelihood that a specific patient will respond to cetuximab. If validated through clinical trials, researchers believe this “green light” tool will help oncologists make better decisions for patients. “We're thrilled to collaborate with Champions Oncology and Dr. David Sidransky at Johns Hopkins University. While Champions is the leader in personalized medicine, we specialize in big data analysis and signaling pathway analysis. Working together, we're the most promising competitor in personalized medicine,” said Alex Zhavoronkov, PhD, CEO of InSilico Medicine, Inc. “Utilizing our TumorGraft platform and signaling pathway analysis from InSilico Medicine, we may decipher pathway activation profiles in cancer patients that lead to a better personalized treatment,” said Keren Paz, PhD, Chief Scientific Office at Champions Oncology Inc. About InSilico Medicine InSilico Medicine, Inc. is a Baltimore-based company utilizing advances in genomics and big data analysis for in silico drug discovery and drug repurposing for aging and age-related diseases. The company utilizes the GeroScope™, OncoFinder™ , Pathway Cloud Intelligence™ and PharmAtlas™ packages for aging and cancer research, pursues internal drug discovery programs, and provides services to pharmaceutical companies. If you have any questions about the science of aging, bioinformatics, or InSilico Medicine's plan in anti-aging research and drug discovery, please call (443) 451- 7212 or visit: http://www.insilicomedicine.com.
Talks@12: The Promises and Perils of Gene Editing
 
01:00:00
Genome reading and editing are exponentially advancing technologies, putting tools such as next-generation sequencing and CRISPR at the forefront of medical research and practice. George Church, a leading innovator in this emerging field, will explore the many promising applications that could significantly impact human health and also discuss the ethical implications facing genetic engineering now and in the future. George Church, PhD Professor of Genetics Harvard-MIT Program in Health Sciences and Technology Harvard Medical School Director, Personal Genome Project Like Harvard Medical School on Facebook: https://goo.gl/4dwXyZ Follow on Twitter: https://goo.gl/GbrmQM Follow on Instagram: https://goo.gl/s1w4up Follow on LinkedIn: https://goo.gl/04vRgY Website: https://hms.harvard.edu/
Bio Analytical
 
00:26
Views: 47 Rashid shaikh
How to Make New Drugs? Start with Basic Research!
 
25:19
Dr. Mark Fishman of the Novartis Institutes for Biomedical Research, discusses several current programs in drug discovery that promise to change the practice of medicine. Each grew from basic science discoveries that were driven by curiosity about the beauty of nature, used strange model organisms, and asked fundamental questions of little presumed relevance to medicine.
Views: 228 Lynn Marquis
Analytical Biochemistry Groningen
 
19:01
This film presents the Analytical Biochemistry Group of Prof. Rainer Bischoff at the University of Groningen, the Netherlands. This group focuses on biomarker research, the design of biopharmaceuticals, and the development of instrumental analytical methods. Prof. Bischoff is the leader of the Biomarker Development Center.
Online Course for Good Documentation Practices (General) - Teaser
 
04:31
Online Course for Good Documentation Practices (General) Speaker Bio: Dr. Afsaneh Motamed Khorasani is a Medical and scientific Affairs expert and a Senior Scientist with a strong background in biomedical science and clinical trial/research. She has a tenured and diverse range of experience in medical affairs, basic and industrial clinical research and development, clinical trials, Medical and regulatory writing and intellectual property. She is currently the Vice President of Medical Affairs at Easy Global Training, which is a US-based firm providing global regulatory, quality and medical affairs training backed by consulting. Before joining this company, Dr. Motamed Khorasani has served as an independent consultant, director of medical affairs, senior medical sciences liaison, senior scientist and senior medical analyst at Merck (MDS), Johnson & Johnson, United States Pharmacopeia Convention (USP), Amgen, Baxter International, Covidien (eV3), Radient Pharmaceuticals, AMDL Diagnostics, Microbix Biosystems, Neometrix Consulting, Mount Sinai Hospital, Princess Margaret Hospital, and Vancouver General Hospital. She has more than 20 years of experience and many National and international certificates in GLP, GMP, ICH-GCP and global regulatory compliance for clinical trials and is a member in a number of professional associations, including: American Association of Cancer Research (AACR), American Medical Writers Association (AMWA), Regulatory Affairs Professional Society (RAPS), American Society of Quality (ASQ), Project Management Institute (PMI), and Intellectual Property Institute of Canada (IPIC). Dr. Motamed Khorasani's research has focused on high throughput approaches in the context of cancer informatics with a particular interest in the use of comparative analysis for the mining of integrated oncology data sets that include protein-protein interaction and gene expression profiling. She has published and presented more than 50 papers, abstracts and articles in highly regarded scientific journals and high profile conferences and scientific meetings. On-Demand Webinar Overview Good documentation Practices (GDP) is an essential factor that needs to be closely followed by the personnel in any regulated environment as a process for a successful project completion including observations of unanticipated responses that are required to be accurately recorded and verified. This 1-hour On-Demand Webinar covers the essentials of GDP, its definition, purpose, and importance. Then expands on general rules and principles of GDP (US & EU), General tips for Laboratory Notebook documentation and finally discussing GDP enforcement by regulatory bodies in different countries with some examples of FDA citations. View the 5 minute Teaser Here: https://youtu.be/o76sy7n-pSk View the list of all of our products Here: http://www.easyglobaltraining.com Learning Highlights Following the completion of this On-Demand Webinar you will gain a basic to moderate knowledge of definition, purpose, importance of GDP, General rules of GDP, GDP as applies to laboratory notebook documentation, US Pharmacopeia General Chapter 1029 introduction “Good Documentation Guidelines”, A very brief introduction to European Union (EU) GDP, and finally its enforcement along with some observation samples from FDA. The outline of this 90 minute On-Demand Webinar includes: Definition, Purpose, and Importance General Rules and Principles of GDP Requirements of Records General Tips in GDP: Signature / initial and the meaning Copying records Document maintenance Recording the time and date Correction of errors Rounding rules Back dating Missing data Voiding / cancelling records Recreating / rewriting records Deviations General Tips for Laboratory Notebook Documentation: Assignment of Lab notebook How to properly document in lab notebooks How to include tables / graphs How to attach instrument print outs How to include metadata How to reference lab notebook How to store the completed lab notebooks US Pharmacopoeia General Chapter 1029 Rules Governing Medicinal Products in the European Union GDP Enforcement Summary References Who Can Benefit From This Course • Anybody who works in a regulated environment • Manufacturing & Production Personnel / Managers • Research and Development Personnel (R&D) / Managers • Quality Assurance & Quality Control Personnel / Managers • Laboratory Personnel / Managers • Validation Specialists • Clinical trial personnel • Project Managers • SKU: OW-BO-0002 • Type: On-Demand Webinar • Format: Video MP4 Play Back • Date of Last Update: Jan 05, 2017 • Duration: 100 minutes • Price: $249.00
Zeping Hu | University of Texas | USA | Metabolomics 2014 | OMICS International
 
18:08
Title: The biological response of human skin tissue to low dose ionizing radiation - from a metabolomic perspective. 3rd International Conference and Exhibition on Metabolomics & Systems Biology March 24-26, 2014, San Antonio, USA OMICS International: http://omicsonline.org Vaccine Conferences: http://conferenceseries.com/immunology-conferences.php Global Medical Conferences: http://conferenceseries.com Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com Global Cancer Conferences: http://cancersummit.org Global Diabetes Conferences: http://diabetesexpo.com Global Dental Conferences: http://dentalcongress.com Global Nursing Conferences: http://nursingconference.com Abstract Understanding how human organs respond to ionizing radiation (IR) at a systems biology level and identifying biomarkers for IR exposure at low doses can help provide a scientific basis for establishing radiation protection standards. Little is known regarding the physiological responses to low dose IR at the metabolite level, which represents the end-point of biochemical processes inside cells. Using a full thickness human skin tissue model and GC-MS-based metabolomic analysis, we examined the metabolic perturbations at three time points (3, 24 and 48 h) after exposure to 3, 10 and 200 cGy of X-rays. PLS-DA score plots revealed dose- and time-dependent clustering between sham and irradiated groups. Importantly, delayed metabolic responses were observed at low dose IR. When compared with the high dose at 200 cGy, a comparable number of significantly changed metabolites were detected 48 h after exposure to low doses (3 and 10 cGy) of irradiation. Biochemical pathway analysis showed perturbations to DNA/RNA damage and repair, lipid and energy metabolisms, even at low doses of IR. Biography Dr. Zeping Hu is a research assistant professor in the Children Research Institute at the University of Texas Southwestern Medical Center at Dallas. He earned his Ph.D. from the National University of Singapore in Metabolomics and Pharmaceutical Sciences and received his post-doctoral training in the field of mass spectrometry and metabolomics with Dr. Richard Smith at Pacific Northwest National Laboratory. His research interest includes metabolomics, metabolic flux analysis, bioanalytical sciences (chromatography and mass spectrometry), drug metabolism and pharmacokinetics, and drug-drug/herb interactions. He is current focusing on the metabolomics (global profiling and targeted analysis) and metabolic flux analysis in stem cells, cancer cells and tissues to address important metabolic questions in stem cell and cancer biology. He is also interested in absolute quantitation of a variety of small handful of metabolites to better understand the target metabolic pathways. The goals of these studies are to understand the metabolic perturbations of stem cells and cancers and to discover diagnostic marker metabolites and novel therapeutic targets. Dr. Hu is the author of ~30 publications and reviewer of over 30 scientific journals in the fields of pharmaceutical sciences, metabolomics and analytical chemistry. He is also on the editorial board of Journal of Chromatography & Separation Techniques.
Controversy Surrounds New Telomere-Measuring Blood Test
 
03:59
For more news visit ☛ http://english.ntdtv.com Follow us on Twitter ☛ http://twitter.com/NTDTelevision Follow us on Facebook ☛ http://facebook.com/NTDTelevision A blood test that determines the length of telomeres, the protective caps at the ends of chromosomes that wear down as we get old, is now on sale to the public. The researchers who developed the test say it will allow people to get a sense of how fast they are aging. Opponents say the test is too simplistic and insist that telomere length is only one factor in the aging process. A new blood test developed in Spain, which measures chromosome tips known as telomeres, is now available to the public. Researchers who developed the test say it offers people the opportunity to find out how fast they are aging and clues on their overall health. Contrary to some media reports, the test does not determine how long a person has left to live. Maria Blasco, the scientist who developed the test, says that it allows scientists to measure a patient's biological age rather than their chronological age based on the length of their telomeres, with shorter, worn-out telomeres indicating an older biological age. Blasco, cofounder of "Life Length," is in charge of the molecular oncology program at Spain's National Cancer Research Center (NCIO) [Maria Blasco, "Life Length" Cofounder]: "This is an indication of the degree of ageing of an organism, so it can be an estimate of the biological age of tissues and cells and it is also an estimate of the risk to develop a certain number of diseases that have already been described in the literature to be associated with having shorter telomeres than normal." Blasco says the presence of short telomeres can indicate how prone a person may be to falling ill with age-related disorders like Alzheimer's, for example. She believes the test will allow patients to act on the results and make lifestyle changes that contribute to a healthier life. [Maria Blasco, "Life Length" Cofounder]: "If a person is aging faster than normal, this is because they have shorter telomeres than normal, and are probably at a higher risk of developing diseases. With this information this patient can change certain life habits that have been shown to accelerate the rate of telomere loss, such as smoking, obesity or bad eating habits." Stephen Matlin is Life Length's chief executive officer (CEO). [Steve Matlin, CEO, "Life Length"]: "Just as the cholesterol test led to the pharmaceutical industry developing what is the most important prescribed medicine today in terms of sales which is Lipitor, we believe this will also support the pharmaceutical and clinical and university industry in developing a drug that will potentially allow to lengthen our lives through impacting telomere length." But the value of measuring telomeres is controversial in the scientific community. Nobel laureate Carol Greider, who shared the 2009 Nobel Prize with Elizabeth Blackburn and Jack Szostak for their research on telomeres, told the journal Science she did not consider the test useful. Dr. Tom Vulliamy, senior lecturer in Molecular Biology at Queen Mary University London, spends some of his time in the laboratory examining telomeres. He says the test has undoubted benefits, but believes it does not provide any useful information for individuals. [Dr. Topm Vulliamy, Senior Lecturer in Microbiology]: "... I would not be wanting to volunteer for this kind of test because I think it's not that informative and I don't think they're being particularly clear. Okay, they're going to get a very good, accurate measurement of the telomere length, no doubt. It's a fantastic test in that respect but what that information then gives you, I don't think they're being particularly clear." Vulliamy believes the test could be useful if conducted over a number of years. Some opponents fear that life insurance companies could use the information to hike up premiums or deny coverage to people whose test results deem them to be in a high risk category. With the controversial test's current cost of $720 U.S. dollars, it may be a number of years before a visit to the doctor includes the question, "How long are your telomeres?"
Views: 5146 NTDTV
GapSummit 2017 - Interview with Dr John Reed
 
05:09
Dr John Reed, Head of Pharma Research & Early Development (pRED) at Roche, share his thoughts on GapSummit, healthcare trends and transition from science to exec role, at world's premier inter-generational leadership summit in biotechnology at Georgetown University, Washington DC, USA. Interviewer: Toryn from Global Biotech Revolution. Follow us on Twitter @GlobalBRev and Facebook: GlobalBiotechRevolution Dr Reed is Global Head of Roche Pharma Research & Early Development (pRED), responsible for directing research and early development activities from target through to Phase II, proof-of-concept studies across all therapeutic areas. He is also a member of Roche’s Corporate Executive Committee, reporting to the company CEO. Before joining Roche in 2013, John was an accomplished physician-scientist. He served as CEO of one the largest non-profit biomedical research institutes in the US, running a laboratory that generated more than 800 research publications and over 90 patents. John was awarded hundreds of research grants, and his work is among the most highly cited in the world. John has served on multiple editorial boards for biomedical research journals, and on various advisory committees and boards for biopharmaceutical and biotechnology companies, as well as public and private, non-profit biomedical research organizations. During his academic career, John held faculty appointments at five different universities. He is a Fellow of the American Association for the Advancement of Science (AAAS) and a recipient of numerous honors and awards for his scientific accomplishments. John is founder or co-founder of several biopharmaceutical and biotechnology companies, and previously served on the board of directors of five publicly listed organizations.
Science Translational Medicine
 
05:54
The journal Science, published by the nonprofit American Association for the Advancement of Science (AAAS), is launching a new journal devoted to translational research, which uses insights from basic biology to improve medical care for human patients. The journal, Science Translational Medicine, is set for launch in fall 2009. This video features Elias Zerhouni, Alan Leshner, Bruce Alberts, and Katrina Kelner. See http://sciencetranslationalmedicine.org.
Views: 9862 wwwAAASorg
Keynote Presentation: Solid Phase Microextraction: New Developments in Bioanalysis..
 
01:11:59
Presented At: LabRoots - Analytical Chemistry Virtual Event 2018 Presented By: Janusz Pawliszyn, PhD - University Professor, Canada Research Chair, Department of Chemistry, University of Waterloo Speaker Biography: Janusz B. Pawliszyn received his early education in Poland. He earned his B.Sc. in Engineering at the Technical University of Gdansk in 1977, his M.S. in organic chemistry at the same university in 1978, and his Ph.D. in analytical chemistry at Southern Illinois University in Carbondale in 1982. Then he spent two years as a Postdoctoral Fellow at the University of Toronto, Canada, and joined the faculty at Utah State University as an Assistant Professor. In 1988 he moved to The University of Waterloo, Waterloo, Ontario where he moved up the ranks to Associate Professor in 1991 and Professor in 1997. Professor Pawliszyn is an author of over 150 scientific publications and has recently published a book on Solid Phase Microextraction. He has graduated numerous M.S. and Ph.D. students as well as hosting many visiting scholars. He has served as a member of the Editorial Boards of Analytical Chemistry, Analyst, Canadian Journal of Chemistry, Electrophoresis, Journal of Microcolumn Separations, and Field Analytical Chemistry and Technology. He received the 1995 McBryde Medal, the 1996 Tswett Medal, the 1996 Hyphenated Techniques in Chromatography Award, the 1996 Caledon Award, the 1998 Jubilee Medal from the Chromatographic Society, U.K., and the 2000 Maxxam Award (CSC). Co-Presented By: Barbara Bojko, PhD - University Professor, Canada Research Chair, Department of Chemistry, University of Waterloo Speaker Biography: Dr. Barbara Bojko is postdoctoral fellow in Prof. Pawliszyn's group at Department of Chemistry, University of Waterloo (Canada) and assistant professor at Department of Medicinal Chemistry, Collegium Medicum Nicolaus Copernicus (Poland). Previously she was an assistant professor at Medical University of Silesia, Poland. In 2001 she obtained her medical diagnostician diploma and master degree, and in 2005 she obtained the PhD (Hon) in pharmaceutical sciences, with specialization in pharmaceutical biochemistry. She is an author of over 40 publications in peer-reviewed journals and two book chapters. She was awarded for her scientific achievements by Minister of Health (2004, 2007, 2011) and for her academic achievements by President of Medical University of Silesia (2009, 2010, 2012). Webinar: Keynote Presentation: Solid Phase Microextraction: New Developments in Bioanalysis and Medical Applications Webinar Abstract: Solid phase microextraction (SPME) is a versatile, non-exhaustive sample preparation tool that has been demonstrated to be well-suited for facile and effective analysis of a broad range of compounds in a plethora of studies. A growing number of reports describing diverse SPME workflows for novel investigations in a variety of fields including diverse bioanalytical applications, among others, corroborate the applicability of this microextraction tool in the bioanalytical sciences. Important bioanalytical applications of SPME include high throughput, in vivo and on-site analysis, in vitro and in vivo metabolomics studies, pharmaceutical and biomedical research. Patient monitoring, metabolomics and biomarkers discovery are an integral part of medical diagnosis and biomedical research. However, tissue analysis remains the bottleneck of such studies due to the invasiveness of presently used sample collection based on biopsy, as well as the laborious and time-consuming sample preparation protocols. In the proposed technology, we have integrated in vivo sampling, sample preparation including global extraction of metabolites together with convenient coupling to analytical instrument.... Learning Objectives: 1. Provide understanding about microextraction approaches and their advantages compared to exhaustive extraction techniques. 2. To demonstrate potential of the SPME technology in biomedical research. Earn PACE/CME Credits: 1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/virtual-event/analytical-chemistry-2018) 2. Watch the webinar on YouTube above or on the LabRoots Website (https://www.labroots.com/virtual-event/analytical-chemistry-2018) 3. Click Here to get your PACE (Expiration date – October 24, 2020 09:00 AM) – https://www.labroots.com/credit/pace-credits/3152/third-party LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc
Views: 56 LabRoots
Comparative study on drug safety surveillance on medical students – Video abstract 85019
 
04:01
Video abstract of original research paper “Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria” published in the journal of Therapeutics and Clinical Risk Management by Abubakar et al. Background: Internationally, there is a remarkable achievement in the areas of drug discovery, drug design, and clinical trials. New and efficient drug formulation techniques are widely available which have led to success in treatment of several diseases. Despite these achievements, large number of patients continue to experience adverse drug reactions (ADRs), and majority of them are yet to be on record. Objectives: The purpose of this survey is to compare knowledge, attitude, and practice with respect to ADRs and pharmacovigilance (PV) between medical students of Malaysia and Nigeria and to determine if there is a relationship between their knowledge and practice. Method: A cross-sectional, questionnaire-based survey involving year IV and year V medical students of the Department of Medicine, Universiti Sultan Zainal Abidin and Bayero University Kano was carried out. The questionnaire which comprised 25 questions on knowledge, attitude, and practice was adopted, modified, validated, and administered to them. The response was analyzed using SPSS version 20. Results: The response rate from each country was 74%. There was a statistically significant difference in mean knowledge and practice score on ADRs and PV between medical students of Malaysia and Nigeria, both at P0.000. No significance difference in attitude was observed at P=0.389. Also, a statistically significant relationship was recorded between their knowledge and practice (r=0.229, P=0.001), although the relationship was weak. Conclusion: Nigerian medical students have better knowledge and practice than those of Malaysia, although they need improvement. Imparting knowledge of ADRs and PV among medical students will upgrade their practice and enhance health care delivery services in the future.
Views: 123 Dove Medical Press
Noscapine-loaded PLA Nanoparticles
 
02:43
Journal: Pharmaceutical Nanotechnology Article: Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency Author(s): Kiran Yadav, Deepak Yadav, Manisha Yadav and Sunil Kumar. Read more: bit.ly/1OBYU7M
Views: 1389 Bentham Science
Journal of Bioprocessing & Biotechniques | OMICS Publishing Group
 
02:20
This video is by OMICS Publishing Group the Journal of Bioprocessing & Biotechniques which focuses in the area of Bioprocess & Bioengineering, Food and Bioprocess Technology, Immobilization Biotechnology, Bioprocessing such as downstream, up-stream processing, bio reactors etc.Journal of Bioprocessing & Biotechniques scrutinize the experimental and theoretical findings and provides an open access to the public which supports a greater global exchange of knowledge in the area of Bioprocessing & Biotechniques. To access more information about Journal of Bioprocessing & Biotechniques please follow OMICS Publishing Group's official page http://www.omicsonline.org/jbpbthome.php
Jan De Backer | FLUIDDA | Belgium | BABE 2014 | OMICS International
 
20:48
Title: Functional Respiratory Imaging (FRI) to assess bio-equivalence of inhaled medication 5th World Congress on Bioavailability and Bioequivalance Pharmaceutical R&D Summit September 29-October 01, 2014 Baltimore , USA OMICS International: http://conferenceseries.com/ Pharmaceutical Conferences: http://pharmaceuticalconferences.com Global OMICS open access Journals: http://omicsonline.org Global MedicaOl Conferences: http://conferenceseries.com Global Cancer Conferences: http://cancersummit.org Global Diabetes Conferences: http://diabetesexpo.com Global Dental Conferences: http://dentalcongress.com Global Nursing Conferences: http://nursingconference.com Abstract Demonstrating bio-equivalence of inhaled drugs is challenging. The conventional pharmacodynamics (PD) endpoints often lack the sensitivity to differentiate between different products while the pharmacokinetic (PK) endpoints are usually too sensitive and subject to batch to batch variability. Functional Respiratory Imaging (FRI) is a novel imaging biomarker used in respiratory drug development, which has the potential to bridge between PD and PK measures. FRI consists of a combination of high resolution computed tomography (HRCT) imaging and computational fluid dynamics (CFD). While the HRCT provides structural information of the respiratory system, CFD yields functional characteristics such as resistances and aerosol deposition characteristics. This study demonstrates that by providing regional characteristics of the airway volumes, airway resistances and aerosol deposition, FRI has an increased sensitivity to differentiate between products. Two examples will be shown, one cross over study between salbutamol and ipratropium bromide in COPD patients and a cross over study using Fluticasone Salmeterol (branded versus generic) in asthma patients. These cases demonstrate that when products are different, unlike the conventional PD measures, FRI can differentiate the two. When products are equivalent, FRI yields additional evidence supporting the claims. In addition when test and reference products are not equivalent, FRI allows identifying the cause (inhalation profile, aerosol deposition, etc) that can lead to product optimization. While still being a novel method, FRI has proven to be very useful in drug development for innovator products and the first results demonstrate a large potential in the field of bio-equivalence. Biography Jan De Backer graduated from Delft University of Technology, The Netherlands as aerospace engineer. He attained an MSc degree in Aerodynamics and specialized in applied biomedical computational fluid dynamics leading to a PhD from the University of Antwerp, Belgium. He is an alumnus of the MBA programs at London Business School, London and Columbia Business School, New York. He has received several awards for his innovative research and his work has been published in international journals. He founded FLUIDDA in 2005 and holds the position as Chief Executive Officer since 2007.
Views: 663 OMICS International
OMICS Group :: International Conference & Exhibition on Pharmaceutical Regulatory Affairs 2011
 
05:00
OMICS Group :: International Conference & Exhibition on Pharmaceutical Regulatory Affairs 23-24 Nov 2012 HICC Hyderabad, India
Obstacles to Unlocking the Human Genome
 
03:43
Complete video at: http://fora.tv/2009/05/19/A_Closer_Look_at_Personal_Genomic_Testing A panel of DNA, policy, and research experts analyze the social implications of pharmaceutical companies and universities patenting the human genome. Ballon compares the argument against releasing genetic information to a 1961 study of cancer diagnosis. ----- Personal genomic testing (the analysis of the DNA of individuals) is now available for less than $400. The consequences of personal genetic testing are often debated, with advocates arguing that genetic data can lead to improved health care and critics warning that consumers may be unduly worried upon learning results. California regulations impose conditions on firms providing personal genomic testing. This symposium examines genomic testing technology, its ramifications, government regulation of the industry, and whether individuals should have their genome analyzed. - Commonwealth Club of California Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. Avey also spent time at Spotfire helping scientists understand the power of data visualization and at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge potential for significant discoveries. However, the lack of sufficient funding to enable adequate studies prompted Avey to think of a new research model. These ideas led to the formation of 23andMe. Her primary interest is the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose. Avey graduated from Augustana College with a B.A. in biology. Daniel Ballon is Senior Policy Fellow in Technology Studies at the Pacific Research Institute. Dr. Ballon's research focuses on policies which promote innovation in the technology sector. He previously spent ten years conducting applied research in biotechnology, and his work has been published in leading biomedical journals. Prior to joining PRI, he served as science and technology policy advisor for former Speaker of the House Newt Gingrich at the American Enterprise Institute. Dr. Ballon received his Ph.D. in Molecular and Cell Biology from the University of California at Berkeley and a B.A. in Molecular Biology and Biochemistry from Wesleyan University. David C. Magnus, Ph.D. is Associate Professor of Pediatrics and Medicine, Stanford University. Magnus is also Director of the Stanford Center for Biomedical Ethics.
Views: 4496 FORA.tv
IPPCR 2016: Ethical Principles in Clinical Research
 
01:05:25
IPPCR 2016: Ethical Principles in Clinical Research Air date: Monday, January 04, 2016, 5:00:00 PM Category: IPPCR Runtime: 01:05:25 Description: The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues. For more information go to http://clinicalcenter.nih.gov/training/training/ippcr1.html Author: Christine Grady, R.N., Ph.D., NIH Permanent link: http://videocast.nih.gov/launch.asp?19408
Views: 3735 nihvcast
Kyrgyzstan Journal of Microbiology
 
01:01
Photon Journal of Microbiology, Photon Foundation Email: [email protected] is World's Most Read Journal in the area of Microbiology: Rank #1 World Report. Submit your manuscript to : [email protected] as attached MS-Word/ pdf file for fast peer review. Photon Foundation Pharmaceutical Compounding Pharmacy Teaching and Practices Biology, Pharmacy and Allied Sciences Research in Ayurveda and Pharmacy Basic Medical Sciences and Pharmacy Pharma and Bio Sciences Community Pharmacy Pharmacy & Industrial Research Medicine and Pharmacy Pharmacy and Health Research Pharmaceutical Research and Development Pharmacy and Nutrition Sciences Scientia Pharmaceutica Phytotherapy Research Pharmacognosy Communications Pharmacognosy Research Pharmacognosy Reviews Pharmacognosy Magazine Molecular Pharmaceutics Controlled Release Geriatric Psychiatry Photon Journal Photon Foundation Advanced https://sites.google.com/site/photonf... Drug Delivery Reviews Drug Development and Industrial Pharmacy Pharmaceutics and Biopharmaceutics Pharmacy Education PHARMACY & LIFE SCIENCE Oncology Pharmacy Practice International conference on Pharmacy national conference on Pharmacy seminar on Pharmacy symposium on Pharmacy exhibition on Pharmacy proceeding on Pharmacy workshop on Pharmacy, B.Pharm, M.Pharm, Pharmacists , Human Anatomy and Physiology; Pharmaceutical Maths & Biostatistics; Biochemistry; Pharmaceutical, Physical Pharmaceutics-I 3. Pharmaceutical Organic Chemistry - II 4. Pharmaceutical Analysis, Pharmaceutical Calculation, PHARMACOGNOSY, CHEMISTRY, Pharmaceutics Advanced Drug Delivery Reviews • Drug Delivery • Drug Development and Industrial Pharmacy • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • Opinion on Biological Therapy • Drug Delivery • Therapeutic Patents • Expert Opinion on Therapeutic Targets • Health Economics • Indian Journal of Pharmaceutical Sciences • International Journal of Geriatric Psychiatry • International Journal of Medical Sciences • International Journal of Pharmaceutics • Journal of Controlled Release • Journal of Pharmacy Practice and Research • Molecular Pharmaceutics • The Pharmaceutical Journal • Pharmacognosy Communications • Pharmacognosy Magazine • Pharmacognosy Research • Pharmacognosy Reviews • Pharmacotherapy • Phytotherapy Research • Scientia Pharmaceutica • Acta Facultatis Pharmaceuticae Universitatis Comenianae • Advanced Drug Delivery Reviews • Advances in Therapy • Alimentary Pharmacology & Therapeutics • The American Journal of Pharmaceutical Education • Annales pharmaceutiques françaises • Annals of Pharmacotherapy • Antibiotics and Chemotherapy • Antimicrobial Agents and Chemotherapy • Antiviral Chemistry & Chemotherapy • Antiviral Research • Asian Journal of Pharmaceutics • Bangladesh Journal of Pharmacology • Behavioural Pharmacology (journal) • Biochemical Pharmacology • BioDrugs • Biological & Pharmaceutical Bulletin • British Journal of Clinical Pharmacology • British Journal of Pharmacology • Canadian Journal of Physiology and Pharmacology • Canadian Pharmacists Journal • Cancer Chemotherapy and Pharmacology • China Pharmacy • Clin-Alert • Clinical and Experimental Pharmacology and Physiology • Clinical Pharmacokinectics • Clinical Pharmacology & Therapeutics • Clinical Pharmacology: Advances and Applications • Clinical Therapeutics • CNS Drugs (journal) • CNS Neuroscience & Therapeutics • The Consultant Pharmacist • Core Evidence • Current Drug Metabolism • Pharmacology • Current Pharmaceutical Design • Current Trends in Biotechnology and Pharmacy Drug and Therapeutics Bulletin • Drug Delivery • Drug Design, Development and Therapy • Drug Development and Industrial Pharmacy Photon Journal of Microbiologyhttps://sites.google.com/site/photonf... Research (journal) • Drug Target Insights • Drug Testing and Analysis • Drugs (journal) • Drugs & Aging • Environmental Toxicology and Pharmacology • European Journal of Clinical Pharmacology • European Journal of Pharmaceutical Sciences • European Journal of Pharmaceutics and Biopharmaceutics • European Journal of Pharmacology • European Neuropsychopharmacology • Experimental and Clinical Psychopharmacology Drug Delivery Drug Discovery • Expert Opinion on Drug Metabolism & Toxicology • Expert Opinion on Drug Safety • Expert Opinion on Emerging Drugs • Expert Opinion on Investigational Drugs • Expert Opinion on Pharmacotherapy Theses and dissertations Networked Digital Library of Theses and Dissertations, NDLTD Finding theses and dissertations Theses Library University Library International Theses Research Methodology Review of Literature Results and Discussion, International Library for Thesis
Views: 2 Xing Xing
Is Science Reliable?
 
09:11
It seems like every few months, there’s some kind of news about problems with the scientific publishing industry. Why does this keep happening? And what can be done to fix the system? Hosted by: Hank Green ---------- Support SciShow by becoming a patron on Patreon: https://www.patreon.com/scishow ---------- Dooblydoo thanks go to the following Patreon supporters -- we couldn't make SciShow without them! Shout out to Justin Ove, Andreas Heydeck, Justin Lentz, Will and Sonja Marple, Benny, Chris Peters, Tim Curwick, Philippe von Bergen, Patrick, Fatima Iqbal, Lucy McGlasson, Mark Terrio-Cameron, Accalia Elementia, Kathy & Tim Philip, charles george, Kevin Bealer, Thomas J., and Patrick D. Ashmore. ---------- Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Instagram: http://instagram.com/thescishow ---------- Sources: https://www.washingtonpost.com/news/morning-mix/wp/2015/03/27/fabricated-peer-reviews-prompt-scientific-journal-to-retract-43-papers-systematic-scheme-may-affect-other-journals/ http://www.nature.com/news/reproducibility-crisis-blame-it-on-the-antibodies-1.17586 http://www.reuters.com/article/us-science-cancer-idUSBRE82R12P20120328 http://www.theatlantic.com/science/archive/2015/08/psychology-studies-reliability-reproducability-nosek/402466/ http://www.nature.com/news/scientific-method-statistical-errors-1.14700?WT.mc_id=TWT_NatureNews http://www.nature.com/news/reproducibility-1.17552 http://www.nature.com/news/policy-nih-plans-to-enhance-reproducibility-1.14586 http://www.nature.com/news/weak-statistical-standards-implicated-in-scientific-irreproducibility-1.14131 http://www.eurekalert.org/emb_releases/2016-03/asa-asa030116.php http://www.eurekalert.org/emb_releases/2016-03/sumc-mp031016.php
Views: 389670 SciShow
Structural bioinformatics strategy in the design of antiviral drugs from natural products
 
43:23
Speaker: Professor Habibah A. Wahab, Dean, School of Pharmaceutical Sciences, University of Science, Malaysia. Abstract: Structural bioinformatics has emerged as a powerful tool to approach the development of structure based drug design (SBDD) due to the availability of vast experimental data generated from X-ray crystallography and NMR spectroscop. These experimental data are important in elucidating atomic details of ligand-target complex. However, in some cases, the structures obtained through these experiments cannot be used directly in SBDD because of significant changes between apo and ligand-bound forms. To overcome this limitation and gain additional insight into the motions occurring during ligand-binding, molecular dynamics simulation is frequently utilised as it allows an improved conformational space sampling. In this talk, I will underline recent advances in the methodologies as well as their application to influenza and dengue antiviral design. I will also highlight some of our works that applied these methods in our quest to better understand how chemical modifications in a series of ligands synthesised from Malaysian natural product scaffolds bring about changes in their binding affinities (structure-activity relationships). From this understanding, we discovered compounds from cinnamic acid as well as lawsone scaffolds which possessed potential antiviral activities at submicromolar concentrations.
EXTRAÇÃO DE ÓLEO ESSENCIAL | HORTELÃ
 
07:12
Extração do óleo essencial da Hortelã, realizado por discentes do curso de Engenharia Agronômica, da turma EA 116. Campus Colorado do Oeste – Rondônia. Referências: ALMEIDA, P.P. Extração de óleo essencial de hortelã (Mentha spicata L.) com misturas de solventes a alta pressão. Disponível em https://repositorio.ufsc.br/handle/123456789/89444 Acesso em 02/12/2016. AZAMBUJA, W. Métodos de Extração de Óleos Essenciais. Disponível em http://www.oleosessenciais.org/metodos-de-extracao-de-oleos-essenciais/ Acesso em 02/12/2016. CHOUDHURY, R. P; KUMAR, A; GARG, A. N. Analysis of Indian min (Mentha Spicata) for essential, trace and toxic elements and its antioxidante beharviour. In press. Journal of Pharmaceutical and Biomedical Analysis, (2006). DEL CASTILLO, M. L. R.; BLANCH, G. P.; HERRAIZ, M. Natural variability of enatiomeric composition of bioactive chiral terpenes in Mentha piperita. Journal of Chromatography A, 2004. DEMO, A.; PETRAKIS, C.; KEFALAS, P.; BOSKOU, D. Nutrient antioxidants in some herbs and Mediterranean plant leaves. Food Rosearch Internacional, Vol 31, No. 5, pp. 351354, 1998. FOGAÇA, J. R. V; Extração de óleos essenciais das plantas. Disponível em http://alunosonline.uol.com.br/quimica/extracao-oleos-essenciais-das-plantas.html Acesso em 02/12/2016. GUERRA, M. P; NODARI, R. O. Biodiversidade: aspectos biológicos, geográficos, legais e éticos. IN: Farmacognosia: da planta ao medicamento. 3.ed.ver. – Porto Alegre/Florianópolis: Ed. Universidade/UFRGS/Ed. Da UFSC, 2001, capítulo 1. HRAS, A. R; HADOLIN, M; KNEZ, Z; BAUMAN, D. Comparison of antioxidative and synergistic effects of Rosemary extract with α-tocopherol, ascorbyl palmitate and citric acid in sunflower oil.Food Chemistry, Volume 71, Issue 2, November 2000, Pages 229-233. POSER, G. L. V: MENTZ, L. A. Diversidade biológica e sistemas de classificação. IN: Farmacognosia: da planta ao medicamento. 3.ed.ver. – Porto Alegre/Florianópolis: Ed. Universidade/UFRGS/Ed. Da UFSC, 2001, capítulo 4.
Views: 3281 EA116 IFRO
UV Vis spectroscopy explained lecture
 
25:06
UV Visible spectroscopy explained lecture - This lecture explains about the UV visible spectroscopy technique.This explains how colorimetric analysis of samples are done using the transmittance and absorbance of the sample molecule using beer Lambert law. UV vis spectroscopy is used to identify the concentration of the test sample. Here I also explained the beer lambert law and how beer lambert law is derived. For more information, log on to- http://www.shomusbiology.com/ Get Shomu's Biology DVD set here- http://www.shomusbiology.com/dvd-store/ Download the study materials here- http://shomusbiology.com/bio-materials.html Remember Shomu’s Biology is created to spread the knowledge of life science and biology by sharing all this free biology lectures video and animation presented by Suman Bhattacharjee in YouTube. All these tutorials are brought to you for free. Please subscribe to our channel so that we can grow together. You can check for any of the following services from Shomu’s Biology- Buy Shomu’s Biology lecture DVD set- www.shomusbiology.com/dvd-store Shomu’s Biology assignment services – www.shomusbiology.com/assignment -help Join Online coaching for CSIR NET exam – www.shomusbiology.com/net-coaching We are social. Find us on different sites here- Our Website – www.shomusbiology.com Facebook page- https://www.facebook.com/ShomusBiology/ Twitter - https://twitter.com/shomusbiology SlideShare- www.slideshare.net/shomusbiology Google plus- https://plus.google.com/113648584982732129198 LinkedIn - https://www.linkedin.com/in/suman-bhattacharjee-2a051661 Youtube- https://www.youtube.com/user/TheFunsuman Thank you for watching the video lecture on UV Vis spectroscopy.
Views: 280141 Shomu's Biology

Cozaar 50 mg picture
Meclizine hcl 25mg ear fluid
Taking 50 mg prednisone 5 days
Salbutamol capsules ventolin 8mg morphine
Mestinon de 60 mg